Want to join the conversation?
$CAG 4Q15 Q&A Update: John, CFO: On Private brands, I think there's certainly upside from recent levels; & this business can be much stronger. The issue we face is different one, we think it will take lot more time & effort; & our view is that it should be done by somebody, so that we can focus on opportunities that pay off earlier by comparison.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.